Answers are grounded in this paper and cite their sources.
Chronic inflammatory diseases remain among the leading causes of death worldwide, highlighting the need for safer and more cost-effective anti-inflammatory agents from natural resources. Fucosterol, a bioactive compound isolated from brown marine algae, has been reported to exhibit various pharmacological properties, including anti-inflammatory activity. However, further investigation is needed to elucidate its mechanisms of action. This study assessed the anti-inflammatory potential of fucosterol using in silico, in vitro, and in vivo approaches. Reverse molecular docking revealed strong binding affinities with interleukin (IL)-6 (–6.3 kcal/mol) and IL-1β (–7.4 kcal/mol), suggesting potential interactions with key inflammatory cytokines. Moreover, absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling highlighted fucosterol’s favorable drug-likeness and toxicity profile. Toxicity assessments, including the MTT assay on Human Embryonic Kidney (HEK293) cells and the zebrafish embryo acute toxicity assay, showed concentration-dependent effects, with half-maximal inhibitory concentration (IC50) and medial lethal concentration (LC50) values of 279.90 μg/mL and 173.60 μg/mL, respectively. In vitro Enzyme-Linked Immunosorbent Assay (ELISA)-based assay using lipopolysaccharide-induced HEK293 cells demonstrated a biphasic response in inhibiting IL-6 (24 and 48 h IC50 = 5.86 and 73.36 μg/mL) and IL-1β (24 and 48 h IC50 = 2.59 and 0.02 μg/mL). Similarly, in vivo analysis using lipopolysaccharide-induced zebrafish embryos showed a significant reduction in IL-6 (24 and 48 h IC50 = 34.54 and 30.28 μg/mL) and IL-1β (24 and 48 h IC50 = 29.39 and 29.61 μg/mL) at higher concentrations. These findings provide valuable insights into fucosterol’s role in modulating inflammatory cytokines, likely through the NF-κB pathway. The study provides a better understanding of fucosterol’s anti-inflammatory mechanisms, supporting its potential for further pharmacological research. Future studies, including clinical validation and mechanistic studies, are necessary to establish its therapeutic use and application.
No takes yet. Share an insight, caveat, or question.
Gaspe et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: